Atlas Trials

A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese Descent

Clinical trial NCT03385369 · COMPLETED

Trial details

NCT number
NCT03385369
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SafetyHealthy Subjects
Start date
2018-01-05
Primary completion
2018-04-12
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.